Chemours Q2 Adj $0.38 Misses $0.57 Estimate, Sales $1.54B Beat $1.53B Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemours (NYSE:CC) reported Q2 earnings of $0.38 per share, missing the $0.57 estimate, and sales of $1.54 billion, slightly beating the $1.53 billion estimate. Earnings decreased by 65.45% year-over-year, while sales decreased by 6.22%.

August 01, 2024 | 8:28 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemours reported Q2 earnings of $0.38 per share, missing the $0.57 estimate, and sales of $1.54 billion, slightly beating the $1.53 billion estimate. Earnings decreased by 65.45% year-over-year, while sales decreased by 6.22%.
The significant miss on earnings per share (EPS) and the substantial year-over-year decline in earnings are likely to negatively impact Chemours' stock price in the short term, despite the slight beat on sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100